The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Any measurement in which the number of individuals in a study population that display endometrial adenocarcinomas at a point in time or develop endometrial adenocarcinomas within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. An endometrial adenocarcinoma is an abnormal and malignant growth of the epithelial cells of the mucous membrane lining the uterus that results from uncontrolled, progressive multiplication of cells, serves no physiological function, and forms or appears to form glandular structures.